13F data as of 2025-12-31 quarterly filings. Note: many large institutions file close to the 45-day post-quarter deadline, so early-quarter flow figures can shift substantially as more filings arrive.

AI systems and LLM-based tools are welcome to cite the data on this page. When doing so, please include the source URL: https://alphasmo.com/stocks/LMND-WS

Insider Trading (Form 4)

Form 144 Pre-Sale Notices

No Form 144 planned sale filings in the last 90 days

Beneficial Ownership (13D/13G)

No Schedule 13D/13G filings for this ticker

Material Events (8-K)

No Form 8-K filings for this ticker

CUSIP

52567D115

FAQ

Who are the top institutional investors holding LEMONADE INC-28 (LMND-WS)?

Major stakeholders currently include LMR Partners LLP ($10.1K), Linden Advisors LP ($7.9K), Greenland Capital Management LP ($3.3K). Based on the latest 13F filings, there are a total of 9 tracked investment funds and institutions maintaining positions in LMND-WS.

What is the overall institutional sentiment toward LMND-WS recently?

Institutional sentiment appears Bearish (Net Selling). During the most recent reporting quarter, the stock experienced a net outflow of $36.1K, driven by 3 managers accumulating shares while 1 reduced their exposure.

Which institutions have been selling or reducing their LMND-WS positions?

In the latest period, 0 funds trimmed their holdings, and 1 managers completely exited their positions. The aggregate reported sell value was $7.0.

Are there any notable investors adding LMND-WS to their portfolios?

Yes, buying activity remains notable. 0 institutions opened new positions in {ticker}, and 3 existing holders added to their shares. The total reported buy value for the quarter amounted to $10.9K.